Collegium Pharmaceutical (COLL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Collegium Pharmaceutical (COLL) is Neutral.

The composite score behind that read is -0.08, weighing +0.27 of bullish evidence against -0.28 bearish.

Collegium Pharmaceutical last closed at $22.09, -0.09% on the session.

Against the IVW growth benchmark the position is -0.89% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

3 graded predictions for COLL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Collegium Pharmaceutical in the 53rd percentile on valuation and the 74th percentile on return on equity, where 100 is best.

Collegium Pharmaceutical is classified under Health Care / Pharmaceuticals, with a market capitalisation of $719.81M.

StockMap tracks Collegium Pharmaceutical as the 68th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Collegium Pharmaceutical ranks 76th of 151 in the group, against a group median of -0.08.